BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Prozac
,
rs4950928
,
FABP1
,
Fatty acid metabolic process
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glycosphingolipid binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Neutrophil of bone marrow
Mononuclear cell of peripheral blood
Whole blood
Monocyte of peripheral blood
Macrophage of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Antiphospholipid syndrome
Infection due to Citrobacter
Contact dermatitis
Pyloric ulcer
Periodontitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
rimcazole
CGP 60474
flavopiridol
Bmp4 protein, mouse
chelerythrine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MYOCD
HS2ST1
PPP2R2C
LRP5
SMARCD1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins.
Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell gr…
The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and…
Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 3…
The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for glycosphingolipid binding
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ